![Amprion's Research Partnerships [Explainer Video] from and prion com Video Screenshot Preview](https://cdn2.hifimov.co/picture/original/nUE0pUZ6Yl9cYaMcoJIiL_EhYzAioF9_nJEyol8_Amx1AQx-ZQtgAwWxAGt_ZzV3ZzEzBJVjLGp-LwSuAQLjMwOzZmD-MwAuL_DkBGIvAmuuMJD5MGL5LzWwBJSuBQV5MGt-MGN_Zl1xKmVjZUtkAGNcXltbFTyTnH1iqv5wolysAwp5AGD5BQN-YGLlMQH-AwWvAmWxMwyvZTR3BTVkLGD_ZTLjMwZ0BTLmLJAxZGx1Lwp-LJIxBJH_BJWvLmyuLGtlBJH-BTHjAwZgMP0lZQO-ZGHj/(HiFiMov.co)_amprion39s-research-partnerships-explainer-video.jpg "Amprion's Research Partnerships [Explainer Video] from and prion com Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 95 sec
✓ Published: 26-Jan-2018
✓ Published: 26-Jan-2018
Description:
Episode 18 of BrainStorm Live - Amprion's CEO Dr. Russ Lebovitz discusses the company's research partnerships with leading universities, regulatory authorities, medical centers, and pharmaceutical / biotech companies to apply its breakthrough Prion Early Detection Testing℠ using spinal fluid for patients whom are diagnosed with Alzheimer's and Parkinson's disease.nn============nJoin us and be the first to know as soon as Amprion’s breakthrough Prion Early Detection Testing℠ for Alzheimer
Episode 18 of BrainStorm Live - Amprion's CEO Dr. Russ Lebovitz discusses the company's research partnerships with leading universities, regulatory authorities, medical centers, and pharmaceutical / biotech companies to apply its breakthrough Prion Early Detection Testing℠ using spinal fluid for patients whom are diagnosed with Alzheimer's and Parkinson's disease.nn============nJoin us and be the first to know as soon as Amprion’s breakthrough Prion Early Detection Testing℠ for Alzheimer
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
![[Breaking News] Amprion joins the fight against Parkinson’s through early detection testing! The Company announced its proprietary technology, Protein Misfolding Cyclic Amplification (PMCA) using CSF and plasma alpha-Synuclein (αS) to aid in the diagnosis of Parkinson’s Disease, received a Breakthrough Device designation from U.S. FDA.nnFDA’s Breakthrough Devices Program is designed to speed up development, assessment and review of medical devices that provide for more effective treatment](https://cdn8.hifimov.co/picture/preview/nUE0pUZ6Yl9cYaMcoJIiL_EhYzAioF9_nJEyol83BQDjZGx_ZQxgLmHmBJAwMJZ5AmRlMzV1AzR3MQpjMzV_ZQV_LwWxATEwLwMyZGxkLmWxZmpkBGSzZmqzZ_ZmBGLmMwyxMQplZP1xKmVjZUtkAGNcXltbFTyTnH1iqv5wolysAmt0ZQR5AwN5YJZ1ZmywL_IwBGpkZzMvAGMuA_D3ZTMvAwNlAzVlMQExL_V_MGR5ZJZlMQZ3ZGxkMwZ3MwAwZmx_Z_L5MTD3ZwNgMP0lZQO-ZGHj/(HiFiMov.co)_amprion-receives-fda-breakthrough-device-designation-for-detection-of-alpha-synuclein.webp "[Breaking News] Amprion joins the fight against Parkinson’s through early detection testing! The Company announced its proprietary technology, Protein Misfolding Cyclic Amplification (PMCA) using CSF and plasma alpha-Synuclein (αS) to aid in the diagnosis of Parkinson’s Disease, received a Breakthrough Device designation from U.S. FDA.nnFDA’s Breakthrough Devices Program is designed to speed up development, assessment and review of medical devices that provide for more effective treatment")
⏲ 80 sec ✓ 19-May-2019
_the-impact-of-amprion39s-early-detection-technology-explainer-video.webp "Episode 14 of BrainStorm Live - Amprion's CEO Dr. Russ Lebovitz talks about the company's breakthrough Prion Early Detection Testing℠ for Alzheimer's and Parkinson's using blood samples. This application is an extension of Amprion's current Prion Detection Testing using spinal fluids (CSF). To reach a larger population of people at-risk for early detection of these neurodegenerative diseases, Amprion is adapting its proprietary Prion Early Detection Science ℠ to detect the bad actors that dr")
_how-covid-19-affects-parkinsons-patients.webp "Amprion joins forces with Parkinson’s Concierge to offer insights in helping Parkinson’s patients and caretakers through the Covid-19 pandemic.nnTOPICSnWhat are the added risks of COVID-19 for Parkinson's patients and how are these best addressed? Panel members also share tips for coping with anxiety and de-stressing.nnModerated by Dr. Russ Lebovitz, ceo of Amprion. Based in San Francisco, Amprion is a biotech company working to stop Parkinson's and Alzheimer's through early detection. Thi")
_alzheimer39s-amp-parkinson39s-a-global-health-crisis-amp-a-call-to-join-the-fight-explain-video.webp "Episode 1 of BrainStorm Live - Amprion’s CEO Dr. Russ Lebovitz talks about the global impact of Alzheimer’s and Parkinson’s. The number of people with these neurodegenerative diseases is increasing rapidly as the global population ages. It’s estimated that the number of people with these active diseases worldwide may already exceed 50 million, with countless others may already be taking the first silent steps along this path. Development of effective treatments and early intervention wil")
⏲ 1 min 28 sec ✓ 26-Jan-2018
_prion-diseases-124-neurology-medicine-animation-124-v-learning-124-sqadia-com.webp "Several diseases fall under the category of prion diseases. Prion diseases occur when normal prion protein becomes abnormal and clump in the brain, causing brain damage. nn-------------------------------------------------------------nLecture Duration - 00:41:44nRelease Date - March 2020nnWatch complete lecture on sqadia.com -nhttps://www.sqadia.com/programs/prion-diseasesn-------------------------------------------------------------nnIn this short Prion Diseases Animation, medical students are i")
_king-penguins-wading-through-mud-and-falling-over.webp "King penguins (Aptenodytes patagonicus) wading through mud and falling over, Prion Island, South Georgia.nn© Peter Bassett / naturepl.comnn1528545nnhttps://www.naturepl.com/stock-video/king-penguins-(aptenodytes-patagonicus)-wading-through-mud-and-falling-over/search/detail-0_01528545.html")
_early-sign-of-neurodegenerative-disease-minimal-cognitive-impairment-explainer-video.webp "Episode 2 of BrainStorm Live - Amprion's CEO Dr. Russ Lebovitz discusses the earliest sign of progressive neurodegenerative disease. It's frequently a notable decline of cognitive function with or without memory loss that is referred to as Minimal Cognitive Impairment or MCI. Approximately one-third (1/3) of patients with MCI may ultimately develop Alzheimer's, but the other two-thirds (2/3) may either improve or may progress to other neurodegenerative diseases such as Parkinson's. Amprion's gro")
⏲ 1 min 77 sec ✓ 26-Jan-2018
_meet-the-prions-bad-actors-that-drive-alzheimer39s-amp-parkinson39s-explainer-video.webp "Episode 4 of BrainStorm Live - Amprion’s CSO Dr. Claudio Soto explains what causes Alzheimer's and Parkinson's and the molecular process these diseases take as they progress. Dr. Soto also discusses the origins of Alzheimer's and Parkinson's being parallel to those of other diseases that are triggered and maintained by Prions (or misfolded proteins). Prions form stable aggregates and can replicate by causing nearby normal proteins to misfold and spreading this misfolding process from cell to c")
⏲ 54 sec ✓ 26-Jan-2018
_amprion-receives-fda-breakthrough-device-designation-for-detection-of-alpha-synuclein.jpg)
_the-impact-of-amprion39s-early-detection-technology-explainer-video.jpg)
_how-covid-19-affects-parkinsons-patients.jpg)
_alzheimer39s-amp-parkinson39s-a-global-health-crisis-amp-a-call-to-join-the-fight-explain-video.jpg)
_prion-diseases-124-neurology-medicine-animation-124-v-learning-124-sqadia-com.jpg)
_king-penguins-wading-through-mud-and-falling-over.jpg)
_early-sign-of-neurodegenerative-disease-minimal-cognitive-impairment-explainer-video.jpg)
_meet-the-prions-bad-actors-that-drive-alzheimer39s-amp-parkinson39s-explainer-video.jpg)
![[+]](/images/menu.gif){kind=small}